ehaweb.org
Coagulation as a target for cancer therapy
EHA Library, jerry Ware, 4930
Vaccination post-transplant
EHA Library, Per Ljungman, 4925
Biological basis of PNH
EHA Library, Lucio Luzzatto, 4918
Hypercoagulability in Sickle Cell Disease
EHA Library, John-John Schnog, 4903
Targeting oncogenic pathways in DLBCL
EHA Library, Franck Morschhauser, 4900
Genetic markers of prognosis in CLL
EHA Library, Andrew Pettitt, 4895
How to detect and measure microparticles
EHA Library, Paul Harrison, 4889
Management & diagnosis of CMV infection
EHA Library, Hermann Einsele, 4923
Biological functions and new developments of erythropoiesis-stimulating agents in management of anemia
EHA Library, Iain Macdougall, 4917
Molecular pathogenesis of DLBCL
EHA Library, Georg Lenz, 4899
The role of antigenic stimulation in CLL Pathogenesis
EHA Library, Kostas Stamatopoulos, 4894
The Platelet sheddome
EHA Library, Lawrence Brass, 4888
Molecular basis of AML
EHA Library, L Bullinger, 4885
Acute Myeloid Leukemia
EHA Library, Hartmut Döhner, 3695
Inflammation and thrombosis
EHA Library, Charles Esmon, 3457
Lessons from congenital disorders of hematopoiesis
EHA Library, Karl Welte, 3456
Patterns of somatic mutation in human cancer genomes
EHA Library, Michael Stratton, 3458
Dose-intensified combined modality treatment with 2 cycles of beacopp escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABDV and IF-RT in patients with early unfavourable Hodgkin lymphoma (HL)…
EHA Library, Andreas Engert, 3586
A common constitutional JAK2 haplotype predisposes to Myeloproliferative neoplasms
EHA Library, Anthony Jones, 3585
Deletion of Dicer1 from Osteoprogenitor cells is sufficient to induce Myelodysplasia and hematopoietic Neoplasia
EHA Library, Marc Raaijmakers, 3584
High-throughput RNA interference screening identifies synthetic lethality between oncogenic KRAS dependency and suppression of STK33
EHA Library, Stefan Fröhling, 3583
Dormancy in Stem Cells
EHA Library, Andreas Trumpp, 3459
Cost management in diagnosis and treatment of hematological disorders
EHA Library, Michael Rawlins, 3454
EHA14 José Carreras Lecture: JAK2V617F Myeloproliferative disorders - A single or several genetic events
EHA Library, William Vainchenker, 3453
EHA14 Introduction of José Carreras winner
EHA Library, Robin Foa, 3698
Treatment of MDS
EHA Library, Mario Cazzola, 3419
Thrombin or factor Xa: does the target matter?
EHA Library, Harry R. Büller, 3439
Transfusion in neonates and children
EHA Library, Naomi Luban, 3443
Risk adapted CLL management
EHA Library, Peter Hillmen, 3391
Current status of treatment with allogeneic SCT with reduced intensity conditioning
EHA Library, Alois Gratwohl, 3435
Interferon in the treatment of MPD
EHA Library, Jean-Jacques Kiladjian, 3423
Do commonly used clinical trial designs reflect clinical reality?
EHA Library, Elihu Estey, 3399
Down and B ALL
EHA Library, Shai Izraeli, 3379
Transfusion problems in stem cell transplantation
EHA Library, Derwood Pamphilon, 3442
Bench to bedside in thrombosis
EHA Library, Trevor Baglin, 3438
Clinical implications of biological markers in CLL
EHA Library, Richard Rosenquist, 3390
Reduced intensity conditioning as a platform for immunotherapy
EHA Library, John Barrett, 3434
A risk stratification based approach to the treatment of primary Myelofibrosis
EHA Library, Ronald Hoffman, 3422
The use of genomics in today's clinical trial design: pitfalls in the statistical evaluation
EHA Library, Richard Simon, 3398
Genetic and epigenetic programs in MLL-rearranged ALL
EHA Library, Scott Armstrong, 3378
Dynamics of hematopoietic stem cell compartments
EHA Library, Markus MANZ, 3406
Anatomy of the stem cell niche
EHA Library, Elaine Dzierzak, 3405
Genetics of Thrombosis
EHA Library, Pieter Reitsma, 3437
Pathogenesis and basic aspects of MDS
EHA Library, Azra Raza, 3417
Pathogenesis of MPD
EHA Library, Robert Kralovics, 3421
Designing and interpreting quality of life and other patient-reported outcomes in clinical trials
EHA Library, Fabio Efficace, 3397
Genetic Profiling in B ALL
EHA Library, Charles Mullighan, 3460
The origin of CLL
EHA Library, Ulf Klein, 3389
Immunobiology of reduced intensity conditioning in SCT
EHA Library, Brenda Sandmaier, 3433
Treatment options for relapsing patients
EHA Library, Christian Gisselbrecht, 3403
Recent advances in the treatment of early stages of Hodgkin lymphoma
EHA Library, Andreas Engert, 3411
Treatment options for myeloma in 2009
EHA Library, Joan Bladé, 3415
Risk adapted treatment of AML
EHA Library, Jorge Sierra, 3383
Second generation TKIs: which and when?
EHA Library, H Kantarjian, 3395
Therapeutic strategies in hairy cell leukemia
EHA Library, Daniel Catovsky, 3447
Pediatric MPD
EHA Library, Maria Luigia Randi, 3427
Diagnosis, treatment and management of Erythrocytosis
EHA Library, Mary Frances McMullin, 3431
Treatment options in von Willebrand Disease
EHA Library, Augusto Federici, 3387
Developing new treatments for diffuse large B cell Lymphoma
EHA Library, Margaret Shipp, 3402
The role of PET in the management of Hodgkin's lymphoma
EHA Library, Andrea Gallamini, 3410
Experimental agents knocking at the door of Myeloma treatment
EHA Library, Nikhil Munshi, 3414
Pediatric AML
EHA Library, Gertjan Kaspers, 3426
Immunological and clinical features of T-cell LGL leukemia
EHA Library, Estella Matutes, 3446
Predictors of clinical severiy in sickle cell disease
EHA Library, Martin Steinberg, 3430
Dynamics of mutated clones
EHA Library, Andreas Hochhaus, 3394
Phenotype, Genotype and Classification in von Willebrand disease
EHA Library, Anne Goodeve, 3386
Minimal residual disease
EHA Library, Giuseppe Saglio, 3382
Von Willebrand factor: its role in haemostasis and thrombosis
EHA Library, Karen Vanhoorelbeke, 3385
NK cell disorders
EHA Library, Gianpietro Semenzato, 3445
Red cell membrane disorders
EHA Library, Mohandas Narla, 3429
Pedriatic MDS
EHA Library, Charlotte Niemeyer, 3425
Pathogenesis of multiple myeloma
EHA Library, Gareth Morgan, 3413
AML biology & leukemic stem cells
EHA Library, Brian Huntly, 3381
Lymphocyte-predominant Hodgkin's lymphoma in children and young adults
EHA Library, Judith Landman-Parker, 3409
Molecular basis of aggressive lymphoma
EHA Library, Andreas Rosenwald, 3401
Stem cell persistence in CML
EHA Library, Michael W Deininger, 3393
EHA14 Opening Ceremony: President's Speech
EHA Library, Wim Fibbe, 3449
EHA14 Opening Ceremony : Congress President's Speech
EHA Library, Rüdiger Hehlmann, 3450
EHA14 José Carreras Young Investigator Award
EHA Library, Catherine Lacombe, 3451
Chronic lymphoid leukemia - current concepts of molecular pathogenesis and therapy
EHA Library, Michael Hallek, 2104
Microparticles, thrombosis and cancer
EHA Library, Bruce Furie, 2105
Stem cells in pre leukemia and leukemia
EHA Library, Tariq Enver, 2106
Molecular pathogenesis of B cell lymphomas
EHA Library, Riccardo Dalla-Favera, 2103
Signature-based approaches to leukemia discovery
EHA Library, Kimberly Stegmaier, 2196
IFN-A Promotes Proliferation of Dormant HSCs in vivo, Making Them Susceptible to Elimination by Chemotherapy
EHA Library, Marieke Essers, 2209
Unique Activating Mutations of JAK2 in The Acute Lymphoblastic Leukemias of Down Syndrome -Biological And Therapeutic Applications
EHA Library, Shai Izraeli, 2208
Superior Efficacy With Bortezomib Plus Melphalan–Prednisone (VMP) Versus Melphalan–Prednisone (MP) Alone In Previously Untreated Multiple Myeloma (MM): Results of The Phase III MMY-3002 Vista Study
EHA Library, Jesús San Miguel, 2207
Biallelic Mutations in The Telomerase Component NHP2 Cause The Premature Ageing Syndrome Dyskeratosis Congenita
EHA Library, Tom Vulliamy, 2206
Mutation in TMPRSS6, a Suppressor of Hepcidin Gene Expression, in Familial Iron Deficiency Anemia
EHA Library, Renzo Galanello, 2205
Relationship between academia and pharma
EHA Library, Mike Greaves, 2198
Chronic myeloid leukemia - yesterday, today and tomorrow
EHA Library, John Goldman, 2197
EHA13 Presentation EHA-José Carreras Young Investigator Fellowship & EHA Fellowships
EHA Library, Christina Mecucci, 2343
EHA13 Opening Ceremony : Congress President's Speech
EHA Library, Niels Borregaard, 2350
EHA13 Opening Ceremony: President's Speech
EHA Library, Wim Fibbe, 2342
Cellular therapy to rebuild immunity after stem cell transplantation
EHA Library, Helen Heslop, 2122
Immunomodulatory drugs (IMiDs) in myelodysplastic syndromes: long-term outcome
EHA Library, Alan List, 2121
Defining the role of epigenetic therapy in myelodysplastic syndromes
EHA Library, Steven Gore, 2120
Pathogenesis and therapeutic targets in myelodysplastic syndromes
EHA Library, Simone Boehrer, 2119
Management of adolescents with acute lymphoblastic leukemia: implications for adult therapy
EHA Library, David Webb, 2118
Molecular pathogenesis of acute lymphoblastic leukemia: an IG/TCR-centric view
EHA Library, Elizabeth Macintyre, 2116

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings